Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV431
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,280
Award facts
- Contract value 100% obligated
- $22,279.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,279.60 to AmerSourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veterans' healthcare programs.
This delivery order is issued under AmerSourceBergen's parent company Cencora's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. XELJANZ XR is a prescription medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, representing the type of specialty pharmaceutical commodity routinely delivered through this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FV431?
SPE2DR26FV431 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV431 worth?
The government has obligated $22,280 on SPE2DR26FV431.
Is contract SPE2DR26FV431 an order under another contract?
Yes. SPE2DR26FV431 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV431 competed?
The extent of competition for SPE2DR26FV431 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award